Fulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023
Fulgent Genetics to release Q3 2023 financial results on November 3, 2023
Positive
Fulgent Genetics will release its third quarter 2023 financial results on November 3, 2023
10/17/2023 - 08:00 AM
EL MONTE, Calif. --(BUSINESS WIRE)--
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced that it will release its third quarter 2023 financial results before the market opens on Friday, November 3, 2023. Management will host a conference call for the investment community the same day at 8:30 AM ET (5:30 AM PT) to discuss the results and answer questions.
The call may be accessed through a live audio webcast on the Investor Relations section of the company’s website, http://ir.fulgentgenetics.com . An audio replay will be available at the same location.
About Fulgent
Fulgent is a technology-based company with a well-established clinical diagnostic business and a therapeutic development business. Fulgent’s clinical diagnostic business offers molecular diagnostic testing services, comprehensive genetic testing, and high-quality anatomic pathology laboratory services designed to provide physicians and patients with clinically actionable diagnostic information to improve the quality of patient care. Fulgent’s therapeutic development business is focused on developing drug candidates for treating a broad range of cancers using a novel nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The Company aims to transform from a genomic diagnostic business into a fully integrated precision medicine company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231017182204/en/
Investor Relations Contact:
melanie@blueshirtgroup.com
Source: Fulgent Genetics, Inc.
When will Fulgent Genetics release its Q3 2023 financial results?
Fulgent Genetics will release its Q3 2023 financial results on November 3, 2023.
What time will the conference call for the investment community take place?
The conference call for the investment community will take place at 8:30 AM ET (5:30 AM PT) on November 3, 2023.
Where can I access the live audio webcast of the conference call?
The live audio webcast of the conference call can be accessed on the Investor Relations section of Fulgent Genetics' website, http://ir.fulgentgenetics.com.
Will there be an audio replay available after the conference call?
Yes, an audio replay will be available at the same location as the live audio webcast.
FLGT Rankings
#4291 Ranked by Stock Gains
FLGT Stock Data
Industry
Dental Laboratories
Sector
Manufacturing
Tags
Health Services, Medical/Nursing Services, Manufacturing, Dental Laboratories
Country
US
City
Temple City
About FLGT
mission developing flexible and affordable genetic testing that improves the everyday lives of those around us. founded in 2011, fulgent began with two simple ideas; flexibility and affordability. today, we strive to create the most effective and wide ranging tests on the market. all of this is done in the pursuit of bettering the everyday lives of our customers. we shine brightest when meaningful relationships, passion, and purpose come together. why fulgent? we are committed to working side-by-side with every one of our clients. this is essential to a strong and successful relationship and is our core way of doing business. we have collaborated with some of the top clinicians in our field who have assisted us in creating our panels, report formatting, and improvements to our website. our approach has always been simple: provide testing based on the specific needs of clinicians and their patients. customer support our support philosophy has always been simple: answer our client's ques
